BioStar Capital

BioStar Capital is a Michigan-based private equity firm specializing in transformative medical technologies. The firm focuses on early-stage investments in the healthcare and biotechnology sectors across the United States. BioStar Capital's team comprises renowned healthcare clinicians, medical thought leaders, and financial professionals, providing a unique combination of clinical expertise and business acumen.

The firm's investment strategy centers on identifying and nurturing innovative medical device companies that address unmet clinical needs. BioStar Capital's portfolio includes companies such as Amplitude Vascular Systems, developing an intravascular lithotripsy device for treating heavily calcified arteries; Medical Microinstruments, which has commercialized a robotic device enabling microsurgical precision; and REVA Medical, known for its bioresorbable scaffold designed to treat below-the-knee peripheral artery disease.

BioStar Capital's approach combines financial investment with clinical insight, aiming to improve patient outcomes and advance healthcare through strategic partnerships and investments in cutting-edge medical technologies.